
NASDAQHealthcareMedical - Care Facilities
Latest quote
$18.475
−$0.1244 · -0.67%
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.
Latest quote
$18.475
−$0.1244 · -0.67%
Regular session · ET · Market data may be delayed.
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.
Day range
Current $18.475
52-week range
Current $18.475
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
82
Deep Value
Sentiment
51
Mixed
Risk
66
High Risk
Momentum
19
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.
Day range
Current $18.475
52-week range
Current $18.475
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.82M USD | 4.01M USD | 3.71M USD | 3.76M USD | 4.56M USD |
| Cost of goods sold | 3.83M USD | 3.25M USD | 2.86M USD | 2.89M USD | 3.31M USD |
| Gross profit | 2.99M USD | 762.16K USD | 842.08K USD | 870K USD | 1.25M USD |
| Research and development | 249 USD | — | — | 17.21K USD | 129.27K USD |
| Selling, general, and administrative | 5.43M USD | 3.34M USD | 4.8M USD | 6.75M USD | 1.81M USD |
| Operating expenses | 5.43M USD | 18.1M USD | 4.8M USD | 13.09M USD | 1.81M USD |
| Interest income | — | — | — | — | 1.92M USD |
| Interest expense | 228.62K USD | 44.89K USD | 23.23K USD | 93.78K USD | 127.13K USD |
| Depreciation and amortization | 406.48K USD | 173.22K USD | 119.35K USD | 172.02K USD | 264.1K USD |
| Operating income | −2.44M USD | −17.34M USD | −3.96M USD | −5.72M USD | −559.99K USD |
| Net income | −2.77M USD | −15.36M USD | −10.04M USD | −24.88M USD | 864.83K USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.